KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $168.2 million.

  • Twist Bioscience's Total Non-Current Liabilities rose 19.07% to $168.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.2 million, marking a year-over-year increase of 19.07%. This contributed to the annual value of $168.2 million for FY2025, which is 19.07% up from last year.
  • Latest data reveals that Twist Bioscience reported Total Non-Current Liabilities of $168.2 million as of FY2025, which was up 19.07% from $141.2 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Total Non-Current Liabilities ranged from a high of $171.9 million in FY2022 and a low of $116.2 million during FY2021.
  • Over the past 3 years, Twist Bioscience's median Total Non-Current Liabilities value was $152.5 million (recorded in 2023), while the average stood at $154.0 million.
  • In the last 5 years, Twist Bioscience's Total Non-Current Liabilities spiked by 86.62% in 2021 and then fell by 11.30% in 2023.
  • Over the past 5 years, Twist Bioscience's Total Non-Current Liabilities (Yearly) stood at $116.2 million in 2021, then surged by 47.95% to $171.9 million in 2022, then declined by 11.30% to $152.5 million in 2023, then dropped by 7.39% to $141.2 million in 2024, then rose by 19.07% to $168.2 million in 2025.